On Wednesday, Fitterfly, a digital health and therapeutics, announced to raise fund $12 million in Series A, which was led by Amazon Smbhav Venture Fund and Fireside Ventures. Existing investors also included named 9 Unicorns, Venture Catalysts and Nihar Parikh, who is the Founder of Health Ventures, and Sriram Natarajan who is the Founder of Molbio.

To increase Diabefly’s reach, their digital therapeutics and clinically proven programme. Also, to prevent and manage reverse diabetes. This fund is also used to enhance the technology stack to give unique clinical insights to FitterFly

• Boat Gears Up for $300-500 Million IPO
• Stocks Under F&O Ban: Gujarat Narmada Valley, Hindustan Copper, and Others
• Pacific Atolls Face $10 Billion Challenge from Rising Seas: World Bank
• India and China Set to Shape the Global Economy’s Future
• SarvaGram Raises Rs 565 Crore Funds Through Series D Funding Round 

Dr Arbinder Singal, CEO and co-founder, of Fitterfly, said, “We want to take our clinically-proven diabetes and weight management system to the people who need it the most. This funding will help us strengthen our research, launch new verticals in the heart health space and grow our customer base by reaching out to people living with diabetes and the universe of doctors and organisations in the field of chronic disease management. Our corporate wellness models push the envelope from ‘tick-mark-based bundling’ to an ‘outcome-based approach’.”